Mylan appoints two members to board
This article was originally published in Scrip
Global pharmaceutical company Mylan has appointed Melina Higgins and Rajiv Malik to its board of directors. Prior to joining Canonsburg, Pennsylvania-based Mylan, Ms Higgins served as a partner and in other senior roles at Goldman Sachs from 1989 until her retirement in January 2010. Mr Malik currently serves as president of Mylan and has held leadership positions at the firm since 2007. With the appointments of Ms Higgins and Mr Malik, Mylan expands its board to 13 members.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.